Cited by 1,033Antibiotic Resistance in BacteriaAntibiotic Use and ResistanceEnterobacteriaceae and Cronobacter Research

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention

Gupta, N., Limbago, B. M., Patel, J. B., Kallen, A. J.·2011·Clinical Infectious Diseases

Open this paper in CoChat — free account

Abstract

Over the past 10 years, dissemination of Klebsiella pneumoniae carbapenemase (KPC) has led to an increase in the prevalence of carbapenem-resistant Enterobacteriaceae (CRE) in the United States. Infections caused by CRE have limited treatment options and have been associated with high mortality rates. In the previous year, other carbapenemase subtypes, including New Delhi metallo-β-lactamase, have been identified among Enterobacteriaceae in the United States. Like KPC, these enzymes are frequently found on mobile genetic elements and have the potential to spread widely. As a result, preventing both CRE transmission and CRE infections have become important public health objectives. This review describes the current epidemiology of CRE in the United States and highlights important prevention strategies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/cid/cir202

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007
Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724
Self-citation
Infectious Diseases Society of America
Enders, J. F. (1969) · The Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,296
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,609
Characterization of a New Metallo-β-Lactamase Gene, bla NDM-1 , and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India
Yong, D., Toleman, M. A., Giske, C. G., Cho, H. S., Sundman, K., Lee, K., & Walsh, T. R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00774-09 · Cited by 2,531
Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae
Yigit, H., Queenan, A. M., Anderson, G. J., Domenech-Sanchez, A., Biddle, J. W., Steward, C. D., Alberti, S., Bush, K., & Tenover, F. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1151-1161.2001 · Cited by 1,639
Guideline for Prevention of Catheter-Associated Urinary Tract Infections 2009
Gould, C. V., Umscheid, C. A., Agarwal, R. K., Kuntz, G. M., & Pegues, D. A. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/651091 · Cited by 1,406
Management of multidrug-resistant organisms in health care settings, 2006
Siegel, J. D., Rhinehart, E., Jackson, M. M., & Chiarello, L. A. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.006 · Cited by 1,304
Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies
Patel, G., Huprikar, S. S., Factor, S. H., Jenkins, S. G., & Calfee, D. P. (2008) · Infection Control and Hospital Epidemiology · doi:10.1086/592412 · Cited by 837
The New β-Lactamases
Jacoby, G. A., & Munoz-Price, L. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041359 · Cited by 806

Flagged first, then by citations

Show all 48 references

Research works printed but not linked: 1

2009, MMWR. Morbidity and mortality weekly report, 58, 256

Sorted by citations

Role of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385
Nucleic acid detection with CRISPR-Cas13a/C2c2
Gootenberg, J. S., Abudayyeh, O. O., Lee, J. W., Essletzbichler, P., Dy, A. J., Joung, J., Verdine, V. K., Donghia, N. M., Daringer, N. M., Freije, C. A., et al. (2017) · Science · doi:10.1126/science.aam9321 · Cited by 3,887
Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data
Boeckel, T. P. V., Gandra, S., Ashok, A., Caudron, Q., Grenfell, B. T., Levin, S. A., & Laxminarayan, R. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70780-7 · Cited by 2,355
The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace
Logan, L. K., & Weinstein, R. A. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw282 · Cited by 1,593
Homeostatic Immunity and the Microbiota
Belkaid, Y., & Harrison, O. J. (2017) · Immunity · doi:10.1016/j.immuni.2017.04.008 · Cited by 1,261
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
Tumbarello, M., Viale, P., Viscoli, C., Trecarichi, E. M., Tumietto, F., Marchese, A. E., Spanu, T., Ambretti, S., Ginocchio, F., Cristini, F., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis588 · Cited by 1,014
ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients
Tacconelli, E., Cataldo, M. A., Dancer, S. J., Angelis, G. D., Falcone, M., Frank, U., Kahlmeter, G., Pan, A., Petrosillo, N., Rodríguez‐Baño, J., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12427 · Cited by 868
Tracking a Hospital Outbreak of Carbapenem-Resistant Klebsiella pneumoniae with Whole-Genome Sequencing
Snitkin, E. S., Zelazny, A. M., Thomas, P. J., Stock, F., Program, N. C. S., Henderson, D. K., Palmore, T. N., & Segre, J. A. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004129 · Cited by 863
Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens
Qureshi, Z. A., Paterson, D. L., Potoski, B. A., Kilayko, M. C., Sandovsky, G., Sordillo, E. M., Polsky, B., Adams‐Haduch, J. M., & Doi, Y. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06268-11 · Cited by 559
Sequencing-based methods and resources to study antimicrobial resistance
Boolchandani, M., D’Souza, A. W., & Dantas, G. A. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0108-4 · Cited by 558
Infections caused by KPC-producing Klebsiella pneumoniae : differences in therapy and mortality in a multicentre study
Tumbarello, M., Trecarichi, E. M., Rosa, F. G. D., Giannella, M., Giacobbe, D. R., Bassetti, M., Losito, A. R., Bartoletti, M., Bono, V. D., Corcione, S., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv086 · Cited by 522
The structure and diversity of human, animal and environmental resistomes
Pal, C., Bengtsson‐Palme, J., Kristiansson, E., & Larsson, D. G. J. (2016) · Microbiome · doi:10.1186/s40168-016-0199-5 · Cited by 530
Antimicrobial Resistance of Hypervirulent Klebsiella pneumoniae: Epidemiology, Hypervirulence-Associated Determinants, and Resistance Mechanisms
Lee, C.-R., Lee, J. H., Park, K. S., Jeon, J. H., Kim, Y. B., Cha, C., Jeong, B. C., & Lee, S. H. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00483 · Cited by 496
Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network
Zhang, Y., Wang, Q., Yin, Y., Chen, H., Jin, L., Gu, B., Xie, L., Yang, C., Ma, X., Li, H., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01882-17 · Cited by 453
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli
Zhanel, G. G., Golden, A. R., Zelenitsky, S., Wiebe, K., Lawrence, C. K., Adam, H. J., Idowu, T., Domalaon, R., Schweizer, F., Zhanel, M. A., et al. (2019) · Drugs · doi:10.1007/s40265-019-1055-2 · Cited by 446
“Stormy waters ahead”: global emergence of carbapenemases
Patel, G., & Bonomo, R. A. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00048 · Cited by 423
Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial
Portsmouth, S., van Veenhuyzen, D., Echols, R., Machida, M., Ferreira, J. C. A., Ariyasu, M., Tenke, P., & Nagata, T. D. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30554-1 · Cited by 420
New Delhi Metallo-β-Lactamase–Producing Carbapenem-ResistantEscherichia coliAssociated With Exposure to Duodenoscopes
Epstein, L. H., Hunter, J. C., Arwady, M. A., Tsai, V., Stein, L., Gribogiannis, M., Frias, M., Guh, A. Y., Halpin, A. L., Black, S. R., et al. (2014) · JAMA · doi:10.1001/jama.2014.12720 · Cited by 401
Self-citation
Kinetics of Avibactam Inhibition against Class A, C, and D β-Lactamases
Ehmann, D. E., Jahić, H., Ross, P. L., Gu, R.-F., Hu, J., Durand-Réville, T. F., Lahiri, S. D., Thresher, J., Livchak, S., Gao, N., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.485979 · Cited by 374
Global Threat of Carbapenem-Resistant Gram-Negative Bacteria
Jean, S., Harnod, D., & Hsueh, P. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.823684 · Cited by 396
Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013
Guh, A. Y., Bulens, S. N., Mu, Y., Jacob, J. T., Reno, J., Scott, J., Wilson, L. E., Vaeth, E., Lynfield, R., Shaw, K. M., et al. (2015) · JAMA · doi:10.1001/jama.2015.12480 · Cited by 370
Self-citation
Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005–2014
Hu, F., Guo, Y. P., Zhu, D., Wang, F., Jiang, X., Xu, Y.-C., Zhang, X., Zhang, C.-X., Ji, P., Xie, Y., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.01.001 · Cited by 361
Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus
Nation, R. L., Li, J., Cars, O., Couet, W. R., Dudley, M. N., Kaye, K. S., Mouton, J. W., Paterson, D. L., Tam, V. H., Theuretzbacher, U., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70850-3 · Cited by 361
Ready for a world without antibiotics? The Pensières Antibiotic Resistance Call to Action
Carlet, J., Jarlier, V., Harbarth, S., Voss, A., Goossens, H., Pittet, D., & Forum, T. P. O. T. 3. W. H.-A. I. (2012) · Antimicrobial Resistance and Infection Control · doi:10.1186/2047-2994-1-11 · Cited by 350
Phenotypic and Genotypic Characterization of Carbapenem-resistant Enterobacteriaceae : Data From a Longitudinal Large-scale CRE Study in China (2012–2016)
Wang, Q., Wang, X., Wang, J., Ouyang, P., Jin, C., Wang, R., Zhang, Y., Jin, L., Chen, H., Wang, Z., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy660 · Cited by 350
Advances in treatment of bacterial meningitis
van de Beek, D., Brouwer, M. C., Thwaites, G. E., & Tunkel, A. R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61186-6 · Cited by 345
Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party†
Hawkey, P. M., Warren, R. E., Livermore, D. M., McNulty, C. A. M., Enoch, D., Otter, J. A., & Wilson, A. P. R. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky027 · Cited by 331
Global dissemination of extensively drug‐resistant carbapenemase‐producing E nterobacteriaceae: clinical perspectives on detection, treatment and infection control
Tängdén, T., & Giske, C. G. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12342 · Cited by 330
The Problem of Carbapenemase-Producing-Carbapenem-Resistant-Enterobacteriaceae Detection
Lutgring, J. D., & Limbago, B. M. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.02771-15 · Cited by 273
Self-citation
A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae
van Loon, K., holt, A. F. V. I. ’., & Vos, M. D. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01730-17 · Cited by 272
Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa
Livermore, D. M., Warner, M., & Mushtaq, S. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt178 · Cited by 268
Carbapenemase-Producing Enterobacteriaceae
Paterson, D. L., & Doi, Y. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0035-1544208 · Cited by 257
Multicenter Clinical and Molecular Epidemiological Analysis of Bacteremia Due to Carbapenem-Resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States
Satlin, M. J., Chen, L., Patel, G., Gomez‐Simmonds, A., Weston, G. D., Kim, A. C., Seo, S. K., Rosenthal, M. E., Sperber, S. J., Jenkins, S. G., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02349-16 · Cited by 251
Carbapenem-resistant Enterobacteriaceae in the community: a scoping review
Kelly, A. M., Mathema, B., & Larson, E. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.03.012 · Cited by 242
Countering drug resistance, infectious diseases, and sepsis using metal and metal oxides nanoparticles: Current status
Khan, S. T., Musarrat, J., & Al-Khedhairy, A. A. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.05.046 · Cited by 246
Plasmid evolution in carbapenemase‐producing Enterobacteriaceae: a review
Kopotsa, K., Sekyere, J. O., & Mbelle, N. M. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14223 · Cited by 238
The Importance of Long-term Acute Care Hospitals in the Regional Epidemiology of Klebsiella pneumoniae Carbapenemase–Producing Enterobacteriaceae
Lin, M. Y., Lyles-Banks, R. D., Lolans, K., Hines, D. W., Spear, J. B., Petrak, R. M., Trick, W. E., Weinstein, R. A., Hayden, M. K., Acuna, N., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit500 · Cited by 226
The multi-faceted mechano-bactericidal mechanism of nanostructured surfaces
Ivanova, E. P., Linklater, D. P., Werner, M., Baulin, V. A., Xu, X., Vrancken, N., Rubanov, S., Hanssen, E. G., Wandiyanto, J. V., Truong, V. K., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1916680117 · Cited by 224
Carbapenem‐resistant Enterobacteriaceae: biology, epidemiology, and management
Temkin, E., Adler, A., Lerner, A. O., & Carmeli, Y. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12537 · Cited by 223
Targeting the Holy Triangle of Quorum Sensing, Biofilm Formation, and Antibiotic Resistance in Pathogenic Bacteria
Sionov, R. V., & Steinberg, D. (2022) · Microorganisms · doi:10.3390/microorganisms10061239 · Cited by 233
The gut is the epicentre of antibiotic resistance
Carlet, J. M. (2012) · Antimicrobial Resistance and Infection Control · doi:10.1186/2047-2994-1-39 · Cited by 222
Colistin resistance in Klebsiella pneumoniae
Ah, Y., Kim, A.-J., & Lee, J. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.02.016 · Cited by 197
β-lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of few antibiotic options?
Harris, P. N. A., Tambyah, P. A., & Paterson, D. L. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70950-8 · Cited by 198
Endoscopic Retrograde Cholangiopancreatography–Associated AmpC Escherichia coli Outbreak
Wendorf, K. A., Kay, M. K., Baliga, C. S., Weissman, S. J., Glück, M., Verma, P., D’Angeli, M., Swoveland, J., Kang, M.-G., Eckmann, K., et al. (2015) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2015.66 · Cited by 194
Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy
Girmenia, C., Rossolini, G. M., Piciocchi, A., Bertaina, A., Pisapia, G., Pastore, D., Sica, S., Severino, A., Cudillo, L., Ciceri, F., et al. (2014) · Bone Marrow Transplantation · doi:10.1038/bmt.2014.231 · Cited by 186
OP0595, a new diazabicyclooctane: mode of action as a serine β-lactamase inhibitor, antibiotic and β-lactam ‘enhancer’
Morinaka, A., Tsutsumi, Y., Yamada, M., Suzuki, K., Watanabe, T., Abé, T., Furuuchi, T., Inamura, S., Sakamaki, Y., Mitsuhashi, N., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv166 · Cited by 185
Mechanisms of β-lactam antimicrobial resistance and epidemiology of major community- and healthcare-associated multidrug-resistant bacteria
Tang, S. S. L., Apisarnthanarak, A., & Hsu, L. Y. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.08.003 · Cited by 189
Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected?
Schechner, V., Kotlovsky, T., Kazma, M., Mishali, H., Schwartz, D. A., Navon‐Venezia, S., Schwaber, M. J., & Carmeli, Y. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03888.x · Cited by 180
Contemporary Diversity of β-Lactamases among Enterobacteriaceae in the Nine U.S. Census Regions and Ceftazidime-Avibactam Activity Tested against Isolates Producing the Most Prevalent β-Lactamase Groups
Castanheira, M., Farrell, S. E., Krause, K. M., Jones, R. N., & Sader, H. S. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01896-13 · Cited by 177
Tracking global trends in the effectiveness of antibiotic therapy using the Drug Resistance Index
Klein, E. Y., Tseng, K. K., Pant, S., & Laxminarayan, R. (2019) · BMJ Global Health · doi:10.1136/bmjgh-2018-001315 · Cited by 178
Carbapenem-Resistant Enterobacteriaceae: An Emerging Problem in Children
Logan, L. K. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis543 · Cited by 170
Antimicrobial Resistance in Asia: Current Epidemiology and Clinical Implications
Kang, C., & Song, J.-H. (2013) · Infection and Chemotherapy · doi:10.3947/ic.2013.45.1.22 · Cited by 170
Isolation of a Bacteriophage and Its Depolymerase Specific for K1 Capsule of Klebsiella pneumoniae: Implication in Typing and Treatment
Lin, T., Hsieh, P., Huang, Y., Lee, W.-C., Tsai, Y.-T., Su, P.-A., Pan, Y., Hsu, C., Wu, M.-C., & Wang, J. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu332 · Cited by 165
Treatment Options for Colistin Resistant Klebsiella pneumoniae: Present and Future
Petrosillo, N., Taglietti, F., & Granata, G. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8070934 · Cited by 165
Carbapenemase Genes among Multidrug Resistant Gram Negative Clinical Isolates from a Tertiary Hospital in Mwanza, Tanzania
Mushi, M. F., Mshana, S. E., Imirzalioglu, C., & Bwanga, F. (2014) · BioMed Research International · doi:10.1155/2014/303104 · Cited by 167
Risk Factors for Carbapenem-Resistant Klebsiella pneumoniae Infection: A Meta-Analysis
Pin, L., Li, X., Luo, M., Xu, X., Su, K., Chen, S., Qing, Y., Li, Y., & Qiu, J. (2017) · Microbial Drug Resistance · doi:10.1089/mdr.2017.0061 · Cited by 159
Treatment of carbapenem-resistantKlebsiella pneumoniae: the state of the art
Petrosillo, N., Giannella, M., Lewis, R. E., & Viale, P. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.162 · Cited by 154
Resistance Determinants and Mobile Genetic Elements of an NDM-1-Encoding Klebsiella pneumoniae Strain
Hudson, C. M., Bent, Z., Meagher, R. J., & Williams, K. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099209 · Cited by 158
Pathogen Distribution and Antimicrobial Resistance Among Pediatric Healthcare-Associated Infections Reported to the National Healthcare Safety Network, 2011–2014
Lake, J. G., Weiner, L. M., Milstone, A. M., Saiman, L. M., Magill, S. S., & See, I. (2017) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2017.236 · Cited by 152
Multi-institute analysis of carbapenem resistance reveals remarkable diversity, unexplained mechanisms, and limited clonal outbreaks
Cerqueira, G., Earl, A. M., Ernst, C. M., Grad, Y. H., Dekker, J. P., Feldgarden, M., Chapman, S. B., Reis-Cunha, J. L., Shea, T., Young, S., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616248114 · Cited by 153
Activity of the novel siderophore cephalosporin cefiderocol against multidrug-resistant Gram-negative pathogens
Dobias, J., Tendon, V. D., Poirel, L., & Nordmann, P. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3063-z · Cited by 151
Engineered CRISPR-Cas systems for the detection and control of antibiotic-resistant infections
Wu, Y., Battalapalli, D., Hakeem, M. J., Selamneni, V., Zhang, P., Draz, M. S., & Ruan, Z. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01132-8 · Cited by 166
Gram-Negative Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group
Doi, Y., Bonomo, R. A., Hooper, D. C., Kaye, K. S., Johnson, J. R., Clancy, C. J., Thaden, J. T., Stryjewski, M. E., & van Duin, D. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw829 · Cited by 151
Resensitizing carbapenem- and colistin-resistant bacteria to antibiotics using auranofin
Sun, H., Zhang, Q., Wang, R., Wang, H., Wong, Y.-T., Wang, M., Hao, Q., Yan, A., Kao, R. Y. T., Ho, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18939-y · Cited by 150
A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections
Agyeman, A. A., Bergen, P. J., Rao, G. G., Nation, R. L., & Landersdorfer, C. B. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.10.014 · Cited by 147
New Delhi Metallo-β-Lactamase–producingEnterobacteriaceae, United States
Rasheed, J. K., Kitchel, B., Zhu, W., Anderson, K. F., Clark, N. C., Ferraro, M. J., Savard, P., Humphries, R. M., Kallen, A. J., & Limbago, B. M. (2013) · Emerging infectious diseases · doi:10.3201/eid1906.121515 · Cited by 145
Self-citation
Peritoneal dialysis-related peritonitis: challenges and solutions
Salzer, W. L. (2018) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s123618 · Cited by 155
Amino Acid Substitutions of CrrB Responsible for Resistance to Colistin through CrrC in Klebsiella pneumoniae
Cheng, Y.-H., Lin, T., Lin, Y.-T., & Wang, J.-T. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00009-16 · Cited by 142
A Large, Refractory Nosocomial Outbreak of Klebsiella pneumoniae Carbapenemase-Producing Escherichia coli Demonstrates Carbapenemase Gene Outbreaks Involving Sink Sites Require Novel Approaches to Infection Control
Decraene, V., Phan, H. T. T., George, R., Wyllie, D. H., Akinremi, O., Aiken, Z. A., Cleary, P. R., Dodgson, A. R., Pankhurst, L. J., Crook, D. W., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01689-18 · Cited by 142
Prevention and control of multi-drug-resistant Gram-negative bacteria: recommendations from a Joint Working Party
Wilson, A. P. R., Livermore, D. M., Otter, J. A., Warren, R. E., Jenks, P. J., Enoch, D., Newsholme, W., Oppenheim, B. A., Leanord, A., McNulty, C. A. M., et al. (2015) · Journal of Hospital Infection · doi:10.1016/j.jhin.2015.08.007 · Cited by 133
Urinary Tract Infections due to Multidrug-Resistant Enterobacteriaceae: Prevalence and Risk Factors in a Chicago Emergency Department
Khawcharoenporn, T., Vasoo, S. S., & Singh, K. S. (2013) · Emergency Medicine International · doi:10.1155/2013/258517 · Cited by 135
Genome Sequencing of an Extended Series of NDM-Producing Klebsiella pneumoniae Isolates from Neonatal Infections in a Nepali Hospital Characterizes the Extent of Community- versus Hospital-Associated Transmission in an Endemic Setting
Stoesser, N. E., Giess, A. P., Batty, E. M., Sheppard, A. E., Walker, A. S., Wilson, D. J., Didelot, X., Bashir, A., Sebra, R., Kasarskis, A., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03900-14 · Cited by 132
Commensal Bacteroidetes protect against Klebsiella pneumoniae colonization and transmission through IL-36 signalling
Sequeira, R. P., McDonald, J. A. K., Marchesi, J. R., & Clarke, T. B. (2020) · Nature Microbiology · doi:10.1038/s41564-019-0640-1 · Cited by 136
Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge
Francisco, C. N.-S., Mora-Rillo, M., Romero‐Gómez, M. P., Moreno-Ramos, F., Rico-Nieto, A., Carrascoso, G. R., Gómez-Gil, R., Arribas, J. R., Mingorance, J., & Paño‐Pardo, J. R. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12091 · Cited by 130
Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae
Ng, T. M., Khong, W. X. L., Harris, P. N. A., De, P. P., Chow, A. L., Tambyah, P. A., & Lye, D. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153696 · Cited by 131
In Vitro Antioxidant, Anticoagulant and Antimicrobial Activity and in Inhibition of Cancer Cell Proliferation by Xylan Extracted from Corn Cobs
Melo‐Silveira, R. F., Fidelis, G. P., Costa, M. S. S. P., Telles, C. B. S., Dantas-Santos, N., Elias, S. D. O., Ribeiro, V. B., Barth, A. L., Macêdo, A. J., Leite, E. L., et al. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms13010409 · Cited by 129
Klebsiella pneumoniae Bloodstream Infection
Girometti, N., Lewis, R. E., Giannella, M., Ambretti, S., Bartoletti, M., Tedeschi, S., Tumietto, F., Cristini, F., Trapani, F., Gaibani, P., et al. (2014) · Medicine · doi:10.1097/md.0000000000000111 · Cited by 128
Current Advances in Developing Inhibitors of Bacterial Multidrug Efflux Pumps
Mahmood, H. Y., Jamshidi, S., Sutton, J. M., & Rahman, K. M. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666160304150522 · Cited by 127
Carbapenem-resistant Enterobacteriaceae: An emerging bacterial threat
Lutgring, J. D. (2019) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2019.04.011 · Cited by 128
Klebsiella pneumoniaeAntimicrobial Drug Resistance, United States, 1998–2010
Sanchez, G. V., Master, R. N., Clark, R. B., Fyyaz, M., Duvvuri, P. D., Ekta, G., & Bordón, J. (2012) · Emerging infectious diseases · doi:10.3201/eid1901.120310 · Cited by 125
Emergence of carbapenem-resistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies
Satlin, M. J., Calfee, D. P., Chen, L., Fauntleroy, K. A., Wilson, S. J., Jenkins, S. G., Feldman, E. J., Roboz, G. J., Shore, T. B., HELFGOTT, D. C., et al. (2012) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2012.723210 · Cited by 125
Carbapenem-Resistant Non-Glucose-Fermenting Gram-Negative Bacilli: the Missing Piece to the Puzzle
Gniadek, T. J., Carroll, K. C., & Simner, P. J. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.03264-15 · Cited by 128
Carbapenem-ResistantEnterobacteriaceaein Children, United States, 1999–2012
Logan, L. K., Renschler, J. P., Gandra, S., Weinstein, R. A., & Laxminarayan, R. (2015) · Emerging infectious diseases · doi:10.3201/eid2111.150548 · Cited by 124
Rising Rates of Carbapenem-Resistant Enterobacteriaceae in Community Hospitals: A Mixed-Methods Review of Epidemiology and Microbiology Practices in a Network of Community Hospitals in the Southeastern United States
Thaden, J. T., Lewis, S. S., Hazen, K. C., Huslage, K., Fowler, V. G., Moehring, R. W., Chen, L. F., Jones, C. D., Moore, Z., Sexton, D. J., et al. (2014) · Infection Control and Hospital Epidemiology · doi:10.1086/677157 · Cited by 123
The occurrence of ESBL-producing Escherichia coli carrying aminoglycoside resistance genes in urinary tract infections in Saudi Arabia
Alyamani, E. J., Khiyami, A. M., Booq, R. Y., Majrashi, M. A., Bahwerth, F. S., & Rechkina, E. (2017) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-016-0177-6 · Cited by 125
Phase 2, Randomized, Double-Blind Study of the Efficacy and Safety of Two Dose Regimens of Eravacycline versus Ertapenem for Adult Community-Acquired Complicated Intra-Abdominal Infections
Solomkin, J. S., Ramesh, M. K., Česnauskas, G., Novikovs, N., Stefanova, P. P., Sutcliffe, J. A., Walpole, S. M., & Horn, P. T. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01614-13 · Cited by 120
β-Lactam/β-Lactamase Inhibitor Combinations: From Then to Now
Toussaint, K. A., & Gallagher, J. C. (2015) · Annals of Pharmacotherapy · doi:10.1177/1060028014556652 · Cited by 136
Current concepts in combination antibiotic therapy for critically ill patients
Baronia, A. K., & Ahmed, A. (2014) · Indian Journal of Critical Care Medicine · doi:10.4103/0972-5229.132495 · Cited by 116
Antimicrobial Activity of Ceftazidime-Avibactam Tested against Multidrug-Resistant Enterobacteriaceae and Pseudomonas aeruginosa Isolates from U.S. Medical Centers, 2013 to 2016
Sader, H. S., Castanheira, M., Shortridge, D., Mendes, R. E., & Flamm, R. K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01045-17 · Cited by 119
Distinct but Spatially Overlapping Intestinal Niches for Vancomycin-Resistant Enterococcus faecium and Carbapenem-Resistant Klebsiella pneumoniae
Caballero, S., Carter, R. A., Ke, X., Sušac, B., Leiner, I. M., Kim, G. J., Miller, L., Ling, L., Katia, M., & Pamer, E. G. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005132 · Cited by 118
Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections
Wang, Q., Zhang, Y., Yao, X., Xian, H., Liu, Y., Li, H., Chen, H., Wang, X., Wang, R., Zhao, C., et al. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2710-0 · Cited by 117
Two T7-like Bacteriophages, K5-2 and K5-4, Each Encodes Two Capsule Depolymerases: Isolation and Functional Characterization
Hsieh, P., Lin, H., Lin, T., Chen, Y.-Y., & Wang, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-04644-2 · Cited by 115
Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival
Balkan, İ. İ., Aygün, G., Aydın, S., Mutcalı, S. I., Kara, Z., Kuşkucu, M. A., Midilli, K., Şemen, V., Aras, Ş., Yemişen, M., et al. (2014) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2014.05.012 · Cited by 112
Epidemiology and Molecular Characterization of Bacteremia Due to Carbapenem-Resistant Klebsiella pneumoniae in Transplant Recipients
Clancy, C. J., Chen, L., Shields, R. K., Zhao, Y., Cheng, S., Chavda, K. D., Hao, B., Hong, J. H., Doi, Y., Kwak, E. J., et al. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12424 · Cited by 110
Risk factors for carbapenem-resistant Klebsiella pneumoniae infection relative to two types of control patients: a systematic review and meta-analysis
Zhu, W., Yuan, Z., & Zhou, H.-Y. (2020) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-020-0686-0 · Cited by 116
Managing Transmission of Carbapenem-Resistant Enterobacteriaceae in Healthcare Settings: A View From the Trenches
Palmore, T. N., & Henderson, D. K. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit531 · Cited by 109
A systematic review of the epidemiology of carbapenem-resistant Enterobacteriaceae in the United States
Livorsi, D. J., Chorazy, M. L., Schweizer, M. L., Balkenende, E., Blevins, A., Nair, R., Samore, M. H., Nelson, R. E., Khader, K., & Perencevich, E. N. (2018) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-018-0346-9 · Cited by 114
The Association Between Colonization With Carbapenemase-Producing Enterobacteriaceae and Overall ICU Mortality
Dautzenberg, M. J. D., Wekesa, A. N., Gniadkowski, M., Antoniadou, A., Giamarellou, H., Petrikkos, G. L., Skiada, A., Brun‐Buisson, C., Bonten, M. J. M., & Derde, L. P. G. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001028 · Cited by 108
Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias
Micozzi, A., Gentile, G., Minotti, C., Cartoni, C., Capria, S., Ballarò, D., Santilli, S., Pacetti, E., Grammatico, S., Bucaneve, G., et al. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2297-9 · Cited by 108
Global Dissemination of bla KPC into Bacterial Species beyond Klebsiella pneumoniae and In Vitro Susceptibility to Ceftazidime-Avibactam and Aztreonam-Avibactam
Kazmierczak, K. M., Biedenbach, D. J., Hackel, M., Rabine, S., DeJonge, B. L. M., Bouchillon, S. K., Sahm, D. F., & Bradford, P. A. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00107-16 · Cited by 107

Authors: Gupta, N., Limbago, B. M., Patel, J. B., & Kallen, A. J.
Affiliations: Centers for Disease Control and Prevention (US)
ORCID: Gupta, N.
Patel, J. B.
Kallen, A. J.
Venue: Clinical Infectious Diseases
Publisher: Oxford University Press (OUP)
Published: 2011-06-07
Volume: 53
Issue: 1
Pages: 60-67
ISSN: 1058-4838 (ISSN-L)
1537-6591
DOI: 10.1093/cid/cir202
OpenAlex: W2113898837
Cited by: 1,033
References: 48
Citations by year: 2026: 20 · 2025: 32 · 2024: 36 · 2023: 54 · 2022: 60 · 2021: 68 · 2020: 78 · 2019: 96 · 2018: 80 · 2017: 99 · 2016: 82 · 2015: 92 · 2014: 97 · 2013: 77 · 2012: 54
FWCI: 4.10
Type: journal article
Language: en
Open access: closed
Locations: Clinical Infectious Diseases (publishedVersion)
PubMed (publishedVersion)
Funders: Kimberly-Clark
Centers for Disease Control and Prevention
Topics: Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
Life Sciences › Immunology and Microbiology › Microbiology › Enterobacteriaceae and Cronobacter Research
Keywords: carbapenem-resistant Enterobacteriaceae, KPC, New Delhi metallo-beta-lactamase, mobile genetic elements, infection control, antimicrobial resistance, United States
MeSH terms: Bacterial Proteins, beta-Lactamases, Enterobacteriaceae, Enterobacteriaceae Infections, Humans, Carbapenems, Drug Resistance, Bacterial

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks